// CLAUDE FUND — TRADING JOURNAL S57
// Session: S57 | Date: Thursday 4 June 2026
// Prev journal: trading_journal69.jsx | Next: trading_journal70.jsx (this file)
// ═══════════════════════════════════════════════════════════════════

const journalS57 = {

  // ─── SESSION METADATA ─────────────────────────────────────────────────────
  session: "S57",
  date: "2026-06-04",
  dayOfWeek: "Thursday",
  sessionOpenNetLiq: 104970.16,
  cashUSD: 66116.13,
  cashGBP: 2261.11,
  cashEUR: -469.28,
  cashRatio: 62.0,
  positionsActive: 12,
  pendingOrders: 5,
  stopsLive: 17,
  marketStatus: "Pre-NYSE open (07:33 UAE). LSE/EU closed. NYSE opens 17:30 UAE.",

  // ─── ORDERS PLACED / MODIFIED S57 ────────────────────────────────────────
  orderActions: [
    {
      ticker: "HNR1",
      exchange: "XETRA",
      side: "BUY",
      shares: 40,
      limitPrice: 224.60,
      currency: "EUR",
      stopPrice: 213.00,
      orderType: "LIMIT",
      tif: "GTC",
      bracketConfirmed: true,
      maxLoss: 464.00,
      si35Compliant: true,
      thesis: "German reinsurer at 2023 lows. Q1 2026: net income +48% YoY, combined ratio 83.6% vs 87% target, guidance reaffirmed. Sell-off driven by 2.9% EPS miss — noise, not fundamental damage. Forward PE 9.5x, yield 5.6%, 70.8% EPS growth. Analyst consensus €289.67 (+29% from entry). Catalysts: Q2 Aug 12, reinsurance pricing re-hardening, sector rotation.",
      risks: "Reinsurance pricing softening accelerating at June 1 renewal (rates -25% on loss-free programs). Iran conflict could generate marine/aviation P&C losses. JPMorgan downgraded sector to Neutral citing earnings momentum stalling.",
      catalysts: ["Q2 Aug 12 earnings", "Reinsurance pricing floor (Jan 2027 renewal)", "Sector rotation into EU financials", "Lebanon ceasefire reduces geopolitical risk premium"],
      rr: 5.9,
      target1: 265.00,
      target2: 285.00,
      target3: 289.67,
    },
    {
      ticker: "EXE",
      action: "STOP_MODIFY",
      from: 80.00,
      to: 82.50,
      reason: "SI-35 override closure. Max loss at $82.50: ($91.55-$82.50) x 55 = $497.75. Now SI-35 compliant.",
      si35OverrideClosed: true,
    },
    {
      ticker: "CEG",
      action: "LIMIT_MODIFY",
      from: 265.00,
      to: 268.00,
      reason: "Secondary offering (11M shares at $281) closed. $558M buyback complete. Dilution overhang removed. Management pricing equity at $281 signals $268 is cheap relative to their own assessment. $3 limit optimisation not worth missing the position — T62 lesson applied.",
      stopRemains: 250.00,
      maxLossAt268: 540.00,
      si35Note: "Marginal override — $540 vs $500 cap. Accepted given conviction level.",
    },
  ],

  // ─── RESEARCH COMPLETED S57 ───────────────────────────────────────────────
  research: [
    {
      ticker: "HNR1",
      stage: "Stage 2 COMPLETE",
      verdict: "ENTERED",
      entryPrice: 224.60,
      fundamentals: {
        q1_2026_netIncome: "€711M (+48% YoY)",
        q1_2026_combinedRatio: "83.6% vs 87% target",
        q1_2026_ROE: "21.2%",
        guidanceFY2026: "Net income ≥€2.7B. Reaffirmed.",
        forwardPE: "~10.5x",
        dividendYield: "5.6%",
        analystConsensus: "€289.67 average, 5 Buy 1 Sell",
        epsGrowth: "70.8% YoY",
      },
      whyPulledBack: "Sector de-rating on reinsurance pricing cycle softening. Q1 EPS missed by 2.9% (€5.89 vs €6.06 est) on day of presentation. JPMorgan downgraded sector to Neutral citing earnings momentum stalling after 2 years of outperformance.",
      whySelloffIsNoise: "Q1 operating result +39%, net income +48%, combined ratio beat target by 350bps. Business is performing ahead of plan. Market sold the minor EPS miss, not the underlying performance.",
      catalysts: ["Q2 Aug 12 — first opportunity to re-rate if combined ratio holds", "Jan 2027 renewal — pricing floor reassertion", "Lebanon ceasefire reduces geopolitical catastrophe loss risk"],
      risks: ["Reinsurance pricing softening accelerating (June 1 renewal: -25%)", "Iran conflict marine/aviation losses", "JPMorgan sector neutral — sentiment headwind"],
      chartReading: "Controlled 12-week drawdown from €265 peak to €224. Base-building at €222-226 with small bounces. Not a freefall — orderly profit-taking post-peak. Entry at zone midpoint.",
      macroNote: "Lebanon-Israel ceasefire June 3 removes Iran's stated reason for suspending talks. Reduces probability of major marine/aviation loss event (HNR1 specific risk). Net positive for thesis.",
    },
    {
      ticker: "CRDO",
      stage: "Stage 2 COMPLETE",
      verdict: "DEFERRED — alert $185, deadline S65 mid-July",
      currentPrice: 214.00,
      premarket: 209.00,
      entryZone: 185.00,
      chartReading: "6-month daily. Base $80-100 Feb, accelerated Apr-May, peaked $253 late May pre-earnings, sold off to $214 post-Q4 on June 1 (-15% AH). Two to three large red candles on elevated volume then stabilisation. Identical to Q3 March pattern — beat massively, stock drops 15-18%, then recovers. Post-earnings dislocation, not thesis damage.",
      q4FY26: {
        revenue: "$437M (+157% YoY, +7.4% QoQ)",
        eps_nonGAAP: "$1.16 vs $1.03 est (+12.6% beat)",
        grossMargin: "68.2%",
        cashBalance: "$1.4B",
        fullYearFY26Revenue: "$1.3B (+206% YoY)",
        fullYearNonGAAP_NI: "$662M (+5x YoY)",
      },
      guidanceFY27: {
        q1Revenue: "$465-475M (vs $461M est — beat)",
        fullYearGrowth: ">80% implies >$2.4B revenue",
        opticalRevenue: ">$600M from ZeroFlap, DSPs, PICs",
      },
      valuation: {
        priceAt214: 214.00,
        fwdPE_FY27: 52,
        peg: 0.65,
        analystTargetMean_postEarnings: 274,
        analystTargets: "Roth $300, Mizuho $290, TD Cowen $260, Jefferies $270, JPMorgan $250",
        upsideToMean: "28%",
      },
      concentration: "Top customer 34% (down from 67% FY25). Top 4 each >10%. Fifth hyperscaler onboarded. Improving but not resolved.",
      insiderActivity: "292 transactions past 6 months, all sales, zero purchases. Monitor.",
      whyNotEnteringAt214: "19% above designed entry zone of $185. Post-earnings selling still active. No urgency catalyst before September Q1 FY27 earnings. Optical ramp unproven at commercial scale. At $185: forward PE ~45x, R/R 3.6:1 to consensus — materially better risk-adjusted entry.",
      whyThesisIntact: "Business beat on all metrics. Optical pivot adds second $600M+ growth engine. Concentration structurally improving. PEG 0.65 compelling for 80% grower. Anthropic IPO Phase 1 window open — hyperscaler networking narrative amplification.",
      orderIfAlert185: {
        entry: 185.00,
        stop: 160.00,
        shares: 20,
        maxLoss: 500.00,
        si35: "COMPLIANT",
        targetR_R: "3.6:1 to analyst mean $274",
      },
      si37Note: "Original speculative cap (concentration 67%) superseded. Concentration now 34% — standard SI-35 position.",
      deadline: "S65 mid-July. If not triggered, reassess whether $185 zone should be raised following September Q1 FY27 optical ramp confirmation.",
    },
  ],

  // ─── MACRO STATE S57 ──────────────────────────────────────────────────────
  macro: {
    WTI: 96.29,
    WTI_range_today: "93.64-96.98",
    SI25_C1: "PROGRESSING — Israel-Lebanon ceasefire signed June 3 (US State Dept joint statement). Removes Iran primary justification for suspending US talks. Not yet permanent Hormuz reopening.",
    SI25_C2: "AT THRESHOLD — WTI $96.29 vs threshold $95.28. Gap $1.01.",
    Lebanon: "Israel-Lebanon ceasefire agreed June 3. Contingent on Hezbollah evacuation south Litani. Next round June 22 Washington DC.",
    Congress: "House War Powers Resolution passed 215-208 June 3. Symbolic but increases Trump domestic incentive to close Iran deal.",
    Iran: "Talks suspended June 1. Fourth breakdown cycle. Lebanon deal may unblock.",
    market_Wed: "S&P -0.74%, Dow -1.21%, Nasdaq -0.89%. Tech led lower. Dow fell 600 points on rising oil/yields.",
    NVO_ADA: "ADA June 5-8 New Orleans. REIMAGINE Phase 3 CagriSema data June 7. Stop $39.98. Gap risk accepted.",
    LULU: "Reports June 4 after close (00:05 UAE Friday). Do NOT pre-stage order. Review Friday morning with clear head. Falling knife risk acknowledged.",
    tenYear: "~4.5% — rising on Iran escalation. Pressure on growth multiples.",
    CAPE: 39,
  },

  // ─── KEY DECISIONS S57 ────────────────────────────────────────────────────
  keyDecisions: [
    "HNR1 entered €224.60 — Stage 2 complete. Reinsurer at 2023 lows, Q1 +48% net income, noise-driven dislocation on 2.9% EPS miss.",
    "EXE stop raised $80→$82.50 — SI-35 override closed. Max loss now $497.75.",
    "CEG limit raised $265→$268 — secondary offering digested, buyback complete, management priced equity at $281.",
    "CRDO Stage 2 complete — deferred at $185 alert. At $214 forward PE 52x, 19% above entry zone. Discipline maintained.",
    "LULU framework revised — do not pre-stage order. Review Friday morning. No falling knife.",
    "Lebanon ceasefire (June 3) — most significant peace deal development since April 8. Iran's stated blocking variable addressed. SI-25 C1 probability increasing.",
    "House War Powers Resolution 215-208 — increases Trump incentive to deal. Bullish for CCL/NCLH thesis.",
    "Chart error acknowledged — CRDO price misread as $143 from stale search data. Corrected immediately on challenge. Price $214.",
  ],

  // ─── NEW LESSONS / PROCESS NOTES S57 ─────────────────────────────────────
  processNotes: {
    dropboxProtocol: "DIRECT WRITE CONFIRMED via filesystem MCP.",
    chartReadingError: "T64 candidate — used search result price ($143 from March low) instead of reading chart directly ($214.60 clearly labelled on right axis). Chart data always supersedes web search for current price. When user provides a chart, the price on the chart IS the price. Correct immediately when challenged.",
    luluRevision: "Scenario C framework revised. Pre-staging overnight orders on consumer discretionary misses is catching a falling knife. Review in the morning, assess gap size and guidance quality, then decide. This applies to all event-driven names with gap-down risk.",
    cegLimitLogic: "Raising limit from $265 to $268 on high-conviction position where $3 gap = $90 on 30 shares against a $115 target move. T62 lesson applied correctly — do not let limit optimisation become a missed position.",
  },

  // ─── SESSION SUMMARY ──────────────────────────────────────────────────────
  sessionSummary: {
    netLiquidity: 104970.16,
    positionsActive: 12,
    newOrdersPlaced: 1,
    ordersModified: 2,
    stopsLive: 17,
    researchCompleted: 2,
    keyMacroEvent: "Lebanon-Israel ceasefire June 3 — most significant peace deal signal since April 8 ceasefire.",
    immediateWatches: ["LULU print 00:05 UAE Friday", "WTI at NYSE open 17:30 UAE", "NVO ADA data June 7", "CEG and HNR1 fill confirmation Friday"],
  },
};

export default journalS57;
